You are here: Home » 
  1. News

| CAN-SHOCK gets off to a start

The ethics committee approved the observational monitoring design for the CAN-SHOCK registry with no further conditions.

Another interesting project conducted by the Institute for Myorcardial Infarction Research can now begin: CAN-SHOCK has received a positive opinion from the ethics committee. The aim of the CAN-SHOCK registry study is to investigate the use of Cangrelor in patients with acute myocardial infarction and PCI after CPR, cardiogenic shock or mechanical or non-invasive ventilation in Germany. With the help of the collected data, evidence on the efficacy and safety of Cangrelor in these high-risk patients will be established. This is a solely retrospective study of patient data collected from medical files. The aim is to collect data from approximately 450 patients in 10-20 clinical trial sites in Germany over a period of 4-6 months.


We would like to get to know you and your ideas.

Start project

Consent to the use of cookies

In order to make our website more appealing to visitors and to enable the use of certain functions, we use cookies on various pages. By continuing to use the website, you consent to the use of cookies. Find out more.

I agree
Scroll to top